(firstQuint)Altis 522 Trial - Treatment of Female Stress Urinary Incontinence.

 This study is a prospective, post-market, multi-center, cohort assessment comparing Altis SIS (n=266) and transobturator and/or retropubic slings (n=133) in the treatment of stress urinary incontinence at up to 40 U.

S.

 and international sites.

 Subjects will be followed for a total of 36 months with scheduled visits at 6, 12, 18, 24 and 36 months.

 The study population will consist of adult female subjects with stress incontinence who are clinically indicated for surgical intervention with a mesh sling.

.

 Altis 522 Trial - Treatment of Female Stress Urinary Incontinence@highlight

The aim of this postmarket study is to compare the safety and effectiveness of the Altis Single Sling (SIS) to an FDA cleared transobturator and/or retropubic sling through 36 months.

